Chris Wagner

Chris Wagner

Algemeen Directeur bij
Immunoflex Therapeutics, Inc.
57 jaar
Health Technology
Consumer Services
Industrial Services

Profiel

Chris Wagner was the founder of Canexia Health, Inc. (Canada), founded in 2012, where the title held was Chief Executive Officer.
Mr. Wagner is also the founder of Aspreva Pharmaceuticals Corp.,Immunoflex Therapeutics, Inc...
Mr. Wagner currently holds the position of Director at Contextual Health since 2019.
Mr. Wagner also serves as Area Manager-New Mexico at Meridian Engineering Co. Former positions include President & Chief Executive Officer at Sirius Genomics, Inc., Director at Emerald Health Therapeutics, Inc. from 2018 to 2019, Independent Director at Filament Health Corp.
from 2021 to 2024, and Principal at Eli Lilly & Co. Education includes undergraduate studies at the University of British Columbia.

Actieve functies van Chris Wagner

BedrijvenFunctieBegin
Directeur/Bestuurslid 01-05-2019
Corporate Officer/Principal -
Immunoflex Therapeutics, Inc.
Algemeen Directeur -

Eerdere bekende functies van Chris Wagner

BedrijvenFunctieEinde
FILAMENT HEALTH CORP. Directeur/Bestuurslid 01-04-2024
EMERALD HEALTH THERAPEUTICS Algemeen Directeur 28-11-2018
Algemeen Directeur -
Oprichter -
ELI LILLY AND COMPANY Corporate Officer/Principal -
Ervaring van Chris Wagner in detail bekijken

Opleiding van Chris Wagner

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

8

Eerstegraads connecties

10

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit10

Health Technology

Health Technology

Consumer Services

Health Technology

Industrial Services

Process Industries

Health Technology

Health Technology

Immunoflex Therapeutics, Inc.

Health Services

  1. Beurs
  2. Insiders
  3. Chris Wagner